ONS 2021 - 46th Annual Congress of Oncology Nursing Society (Virtual Meeting)
Apr 20 - Apr 29, 2021 | Washington, DCUS
LARVOL is not affiliated with 46th Annual Congress of Oncology Nursing Society (Virtual Meeting) and all trademarks, logos, and brand names are property of their respective owners
Showing 13 abstracts linked to Trials
[VIRTUAL] Nursing Experience With the Use of Ibrutinib for the First-Line Treatment of Patients With High-Risk Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
[VIRTUAL] SAFETY AND MANAGEMENT OF ADVERSE EVENTS WITH CILTACABTAGENE AUTOLEUCEL, A CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL RESULTS FROM CARTITUDE-1
[VIRTUAL] Nursing Experience With Patients Receiving Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenstrom s Macroglobulinemia: Five Years of Follow-Up From the Phase 3 iNNOVATETM Study
[VIRTUAL] Long-term Efficacy of Neratinib in HER2-Positive Early-Stage Breast Cancer: Overall Survival and Central Nervous System Outcomes from the Phase 3 ExteNET Trial
[VIRTUAL] Isatuximab Updates for Nurses: Isatuximab Plus Carfilzomib and Dexamethasone Versus Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Patients (IKEMA)
[VIRTUAL] Darolutamide significantly improves overall survival with a tolerable safety profile in men with non-metastatic castration-resistant prostate cancer
[VIRTUAL] What Can Patients With Prostate Cancer Expect From Treatment With Apalutamide? Health-Related Quality of Life in Patients With Nonmetastatic Castration-Resistant Prostate Cancer in the Phase 3 SPARTAN Study
[VIRTUAL] Real-World Prognostic Biomarker Testing and Nursing Experience from the Prospective Observational Registry informCLL for Patients Receiving Treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
[VIRTUAL] Treatment Experience and Pyrexia Management in a Patient With Stage III Melanoma Receiving Adjuvant BRAF/MEK-Targeted Therapy
[VIRTUAL] Treatment experience with encorafenib plus binimetinib for BRAF V600-mutant metastatic melanoma: management insights for clinical practice
[VIRTUAL] The Time Course of Adverse Events During Dostarlimab Treatment in Mismatch Mutation Repair Deficient and Proficient Endometrial Cancer Patients in the GARNET Trial
[VIRTUAL] Treatment with Enzalutamide in Men with Non-metastatic Prostate Cancer from the PROSPER Trial
[VIRTUAL] The Feasibility and Preliminary Efficacy of a Self-Advocacy Serious Game Intervention for Women with Advanced Breast or Gynecologic Cancer: A Pilot Randomized Clinical Trial